Daniel E. Rusyniak

3.7k total citations · 1 hit paper
82 papers, 2.4k citations indexed

About

Daniel E. Rusyniak is a scholar working on Toxicology, Cellular and Molecular Neuroscience and Emergency Medicine. According to data from OpenAlex, Daniel E. Rusyniak has authored 82 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Toxicology, 18 papers in Cellular and Molecular Neuroscience and 13 papers in Emergency Medicine. Recurrent topics in Daniel E. Rusyniak's work include Forensic Toxicology and Drug Analysis (20 papers), Neurotransmitter Receptor Influence on Behavior (14 papers) and Cannabis and Cannabinoid Research (9 papers). Daniel E. Rusyniak is often cited by papers focused on Forensic Toxicology and Drug Analysis (20 papers), Neurotransmitter Receptor Influence on Behavior (14 papers) and Cannabis and Cannabinoid Research (9 papers). Daniel E. Rusyniak collaborates with scholars based in United States, Kenya and Australia. Daniel E. Rusyniak's co-authors include Jon E. Sprague, Blake Froberg, Edward Mills, Dmitry V. Zaretsky, Kristine Nañagas, Maria V. Zaretskaia, Danyal Ibrahim, Joseph A. DiMicco, Mark A. Kirk and Louise Kao and has published in prestigious journals such as JAMA, PLoS ONE and Stroke.

In The Last Decade

Daniel E. Rusyniak

77 papers receiving 2.4k citations

Hit Papers

Goldfrank’s Toxicologic Emergencies 2007 2026 2013 2019 2007 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel E. Rusyniak United States 27 444 433 365 311 274 82 2.4k
Jean‐Claude Alvarez France 32 482 1.1× 228 0.5× 364 1.0× 499 1.6× 314 1.1× 215 3.4k
Douglas E. Rollins United States 35 818 1.8× 338 0.8× 287 0.8× 430 1.4× 173 0.6× 113 3.4k
Sotiris Athanaselis Greece 25 705 1.6× 208 0.5× 224 0.6× 302 1.0× 235 0.9× 110 2.1k
Santiago Nogué Spain 21 383 0.9× 486 1.1× 240 0.7× 535 1.7× 259 0.9× 193 2.6k
Michael Shannon United States 25 270 0.6× 606 1.4× 219 0.6× 732 2.4× 257 0.9× 70 3.0k
A. Schmoldt Germany 23 772 1.7× 380 0.9× 324 0.9× 441 1.4× 292 1.1× 112 2.9k
A. Tracqui France 30 800 1.8× 426 1.0× 224 0.6× 341 1.1× 196 0.7× 116 2.6k
B. Zane Horowitz United States 25 239 0.5× 446 1.0× 152 0.4× 251 0.8× 189 0.7× 98 1.7k
Yale H. Caplan United States 28 1.2k 2.7× 413 1.0× 294 0.8× 381 1.2× 186 0.7× 97 2.5k
Gail Cooper United States 22 1.1k 2.5× 282 0.7× 238 0.7× 225 0.7× 362 1.3× 70 2.0k

Countries citing papers authored by Daniel E. Rusyniak

Since Specialization
Citations

This map shows the geographic impact of Daniel E. Rusyniak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel E. Rusyniak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel E. Rusyniak more than expected).

Fields of papers citing papers by Daniel E. Rusyniak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel E. Rusyniak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel E. Rusyniak. The network helps show where Daniel E. Rusyniak may publish in the future.

Co-authorship network of co-authors of Daniel E. Rusyniak

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel E. Rusyniak. A scholar is included among the top collaborators of Daniel E. Rusyniak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel E. Rusyniak. Daniel E. Rusyniak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rusyniak, Daniel E., et al.. (2024). Plasma drug screening using paper spray mass spectrometry with integrated solid phase extraction. Drug Testing and Analysis. 17(1). 138–151. 6 indexed citations
2.
Blackburn, Justin, et al.. (2020). Indiana’s Section 1115 Medicaid Waiver And Interagency Coordination Improve Enrollment For Justice-Involved Adults. Health Affairs. 39(11). 1891–1899. 5 indexed citations
4.
Zaretsky, Dmitry V., et al.. (2018). Automatic analysis of treadmill running to estimate times to fatigue and exhaustion in rodents. PeerJ. 6. e5017–e5017. 14 indexed citations
5.
Tormoehlen, Laura M. & Daniel E. Rusyniak. (2018). Neuroleptic malignant syndrome and serotonin syndrome. Handbook of clinical neurology. 157. 663–675. 33 indexed citations
7.
LaPradd, Michelle, et al.. (2015). Exercise activates compensatory thermoregulatory reaction in rats: a modeling study. PMC.
8.
Zaretsky, Dmitry V., Maria V. Zaretskaia, Pamela J. Durant, & Daniel E. Rusyniak. (2014). Inhibition of the dorsomedial hypothalamus, but not the medullary raphe pallidus, decreases hyperthermia and mortality from MDMA given in a warm environment.. PMC. 2 indexed citations
9.
Banks, Matthew L., Travis J. Worst, Daniel E. Rusyniak, & Jon E. Sprague. (2014). Synthetic Cathinones (“Bath Salts”). Journal of Emergency Medicine. 46(5). 632–642. 86 indexed citations
10.
Rusyniak, Daniel E., Dmitry V. Zaretsky, Maria V. Zaretskaia, & Joseph A. DiMicco. (2011). The role of orexin-1 receptors in physiologic responses evoked by microinjection of PgE2 or muscimol into the medial preoptic area. Neuroscience Letters. 498(2). 162–166. 19 indexed citations
11.
Zaretsky, Dmitry V., Maria V. Zaretskaia, Daniel E. Rusyniak, & Joseph A. DiMicco. (2011). Stress-free microinjections in conscious rats. Journal of Neuroscience Methods. 199(2). 199–207. 9 indexed citations
12.
Zaretsky, Dmitry V., Andrei I. Molosh, Maria V. Zaretskaia, Daniel E. Rusyniak, & Joseph A. DiMicco. (2010). Increase in plasma ACTH induced by urethane is not a consequence of hyperosmolality. Neuroscience Letters. 479(1). 10–12. 2 indexed citations
13.
Sprague, Jon E., et al.. (2005). Carvedilol reverses hyperthermia and attenuates rhabdomyolysis induced by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) in an animal model*. Critical Care Medicine. 33(6). 1311–1316. 57 indexed citations
14.
Mills, Edward, Daniel E. Rusyniak, & Jon E. Sprague. (2004). The role of the sympathetic nervous system and uncoupling proteins in the thermogenesis induced by 3,4-methylenedioxymethamphetamine. Journal of Molecular Medicine. 82(12). 787–799. 66 indexed citations
15.
Rusyniak, Daniel E., et al.. (2003). Dimercaptosuccinic acid is ineffective in the treatment of acute thallium poisoning. Toxicological Sciences. 72. 22. 2 indexed citations
16.
Jones, James H., Christopher S. Weaver, Daniel E. Rusyniak, Edward J. Brizendine, & Roland B. McGrath. (2002). Impact of Emergency Medicine Faculty and an Airway Protocol on Airway Management. Academic Emergency Medicine. 9(12). 1452–1456. 9 indexed citations
17.
Holstege, Christopher P., Michael R. Baylor, & Daniel E. Rusyniak. (2002). Absinthe: Return of the Green Fairy. Seminars in Neurology. 22(1). 89–94. 17 indexed citations
18.
Rusyniak, Daniel E., R. Brent Furbee, & Mark A. Kirk. (2002). Thallium and arsenic poisoning in a small midwestern town. Annals of Emergency Medicine. 39(3). 307–311. 34 indexed citations
19.
Rusyniak, Daniel E.. (2001). Pearls and Pitfalls in the Approach to Patients with Neurotoxic Syndromes. Seminars in Neurology. 21(4). 407–416. 1 indexed citations
20.
Bennett, Barbara A., et al.. (1995). HIV-1 gp120-induced neurotoxicity to midbrain dopamine cultures. Brain Research. 705(1-2). 168–176. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026